* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Gene Section MXI1 (MAX interactor 1) Atlas of Genetics and Cytogenetics
Epigenetics of diabetes Type 2 wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Frameshift mutation wikipedia , lookup
Gene desert wikipedia , lookup
Long non-coding RNA wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Gene therapy wikipedia , lookup
Gene expression programming wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Primary transcript wikipedia , lookup
Gene nomenclature wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Gene expression profiling wikipedia , lookup
Cancer epigenetics wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Microevolution wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Genome (book) wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Designer baby wikipedia , lookup
Mir-92 microRNA precursor family wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Point mutation wikipedia , lookup
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Mini Review MXI1 (MAX interactor 1) Niels B Atkin Department of Cancer Research, Mount Vernon Hospital, Northwood, Middlesex, UK (NBA) Published in Atlas Database: December 1999 Online updated version : http://AtlasGeneticsOncology.org/Genes/MXI1ID209.html DOI: 10.4267/2042/37556 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 1999 Atlas of Genetics and Cytogenetics in Oncology and Haematology Homology Identity Belongs to the basic helix-loop-helix (bhlh) family of transcription factors. HGNC (Hugo): MXI1 Location: 10q24-25 Mutations DNA/RNA Somatic Description Mutations have been described in some sporadic prostate cancers but no germline mutations were found in a study of 38 families with possible predisposition to this disease; a correlation between a polymorphic repeat in the 3' untranslated region in Mxil mRNA and regulation of its transcription and degradation has been suggested. The gene spans approximately 60 kb; 6 exons. Transcription 2.6 kb mRNA; two transcription initiation sites. Protein Description Implicated in 228 amino acids; 26 kDa; contains a basic region/helixloop-helix/leucine zipper (B-HLH-LZ) motif that is similar to that found in Myc family. Implicated in some sporadic cases of prostate cancer and glioblastoma as a tumour suppressor gene Expression Tissue specific; differentiation. induced during cells References terminal Zervos AS, Gyuris J, Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell. 1993 Jan 29;72(2):223-32 Localisation Nuclear. Albarosa R, DiDonato S, Finocchiaro G. Redefinition of the coding sequence of the MXI1 gene and identification of a polymorphic repeat in the 3' non-coding region that allows the detection of loss of heterozygosity of chromosome 10q25 in glioblastomas. Hum Genet. 1995 Jun;95(6):709-11 Function Mxil, discovered in 1993, is, with Mad, one of the proteins that can regulate Max, a human protein containing a basic helix-loop-helix leucine zipper (bHLH-zip) that allows the formation of cMyc-Max heterodimers and that activates transcription; Mad and Mxil may be involved in tumour suppression since they can compete with Myc proteins for the interaction with Max; Mxil normally functions to suppress cell growth: experimental induction of the gene resulted in the accumulation of cells in G2-M phase. Atlas Genet Cytogenet Oncol Haematol. 1999; 3(4) Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV. Mutation of the MXI1 gene in prostate cancer. Nat Genet. 1995 Mar;9(3):249-55 Kawamata N, Park D, Wilczynski S, Yokota J, Koeffler HP. Point mutations of the Mxil gene are rare in prostate cancers. Prostate. 1996 Sep;29(3):191-3 Lacombe L, Orlow I, Reuter VE, Fair WR, Dalbagni G, Zhang ZF, Cordon-Cardo C. Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer. Int J Cancer. 1996 Apr 22;69(2):110-3 185 MXI1 MAX interactor 1 Atkin NB Shimizu E, Shirasawa H, Kodama K, Sato T, Simizu B. Expression, regulation and polymorphism of the mxi1 genes. Gene. 1996 Oct 17;176(1-2):45-8 Benson LQ, Coon MR, Krueger LM, Han GC, Sarnaik AA, Wechsler DS. Expression of MXI1, a Myc antagonist, is regulated by Sp1 and AP2. J Biol Chem. 1999 Oct 1;274(40):28794-802 Edwards SM, Dearnaley DP, Ardern-Jones A, Hamoudi RA, Easton DF, Ford D, Shearer R, Dowe A, Eeles RA. No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group. Br J Cancer. 1997;76(8):992-1000 Foley KP, Eisenman RN. Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network. Biochim Biophys Acta. 1999 May 31;1423(3):M37-47 Lee TC, Ziff EB. Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF. J Biol Chem. 1999 Jan 8;274(2):595-606 Wechsler DS, Shelly CA, Petroff CA, Dang CV. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Res. 1997 Nov 1;57(21):4905-12 This article should be referenced as such: Atkin NB. MXI1 (MAX interactor 1). Atlas Genet Cytogenet Oncol Haematol. 1999; 3(4):185-186. Schreiber-Agus N, DePinho RA. Repression by the Mad(Mxi1)Sin3 complex. Bioessays. 1998 Oct;20(10):808-18 Atlas Genet Cytogenet Oncol Haematol. 1999; 3(4) 186